Erakusten 1 - 14 emaitzak -- 14 bilaketa honetara 'Michael K. Racke', Bilaketaren denbora: 0,03s Findu emaitzak
  1. 1
    Editorial: Challenges in developing new multiple sclerosis therapies

    Editorial: Challenges in developing new multiple sclerosis therapies nork Michael K. Racke

    Argitaratua 2008-09-01
    Testu osoa
    Artikulua
  2. 2
    Natalizumab: increased vigilance is required in treating patients with multiple sclerosis

    Natalizumab: increased vigilance is required in treating patients with multiple sclerosis nork Michael K. Racke, Olaf Stüve

    Argitaratua 2008-11-01
    Testu osoa
    Artikulua
  3. 3
    PPARs in Neuroinflammation

    PPARs in Neuroinflammation nork Paul D. Drew, Michael K. Racke

    Argitaratua 2008-01-01
    Testu osoa
    Artikulua
  4. 4
    Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes

    Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes nork Michael K. Racke, Elliot M. Frohman, Teresa Frohman

    Argitaratua 2022-01-01
    Testu osoa
    Artikulua
  5. 5
    Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs

    Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs nork Yuhong Yang, Amy E. Lovett-Racke, Michael K. Racke

    Argitaratua 2010-01-01
    Testu osoa
    Artikulua
  6. 6
    PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis

    PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis nork Michael K. Racke, Paul D. Drew, Amy Lovett-Racke, Yuhong Yang, Anne R. Gocke

    Argitaratua 2008-01-01
    Testu osoa
    Artikulua
  7. 7
    Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients.

    Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients. nork Karen Yao, Susan Gagnon, Nahid Akhyani, Elizabeth Williams, Julie Fotheringham, Elliot Frohman, Olaf Stuve, Nancy Monson, Michael K Racke, Steven Jacobson

    Argitaratua 2008-01-01
    Testu osoa
    Artikulua
  8. 8
    PEG minocycline-liposomes ameliorate CNS autoimmune disease.

    PEG minocycline-liposomes ameliorate CNS autoimmune disease. nork Wei Hu, Josbert Metselaar, Li-Hong Ben, Petra D Cravens, Mahendra P Singh, Elliot M Frohman, Todd N Eagar, Michael K Racke, Bernd C Kieseier, Olaf Stüve

    Argitaratua 2009-01-01
    Testu osoa
    Artikulua
  9. 9
    A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance

    A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance nork Saba I. Aqel, Xiaozhi Yang, Emma E. Kraus, Jinhua Song, Marissa F. Farinas, Erin Y. Zhao, Wei Pei, Amy E. Lovett-Racke, Michael K. Racke, Chenglong Li, Yuhong Yang

    Argitaratua 2021-02-01
    Testu osoa
    Artikulua
  10. 10
    Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.

    Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis. nork Nancy L Monson, Petra Cravens, Rehana Hussain, Christopher T Harp, Matthew Cummings, Maria de Pilar Martin, Li-Hong Ben, Julie Do, Jeri-Anne Lyons, Amy Lovette-Racke, Anne H Cross, Michael K Racke, Olaf Stüve, Mark Shlomchik, Todd N Eagar

    Argitaratua 2011-02-01
    Testu osoa
    Artikulua
  11. 11
    Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment

    Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment nork Darren M. Weber, Steven W. Taylor, Robert J. Lagier, Jueun C. Kim, Scott M. Goldman, Nigel J. Clarke, David E. Vaillancourt, Ranjan Duara, Ranjan Duara, Karen N. McFarland, Wei-en Wang, Todd E. Golde, Todd E. Golde, Michael K. Racke

    Argitaratua 2024-03-01
    Testu osoa
    Artikulua
  12. 12
    K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity

    K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity nork Qiuming Zeng, Hui Guo, Na Tang, Pranav S. Renavikar, Nitin J. Karandikar, Amy E. Lovett-Racke, Michael K. Racke, Chengkai Yan, Rong Tang, Sushmita Sinha, Krishnendu Ghosh, Jeremy P. Ryal, Song Ouyang, Min Chen, Foued Amari, Coppola Vincenzo, R. Marshall Pope, Yalan Li, Huan Yang, Wallace Y. Langdon, Jian Zhang

    Argitaratua 2025-02-01
    Testu osoa
    Artikulua
  13. 13
    A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis

    A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple scler... nork Elliot M. Frohman, Gary Cutter, Gina Remington, Hongjiang Gao, Howard Rossman, Bianca Weinstock-Guttman, Jacqueline E. Durfee, Amy Conger, Ellen Carl, Katherine Treadaway, Eric Lindzen, Amber Salter, Teresa C. Frohman, Anjali Shah, Angela Bates, Jennifer L. Cox, Michael G. Dwyer, Olaf Stuve, Benjamin M. Greenberg, Michael K. Racke, Robert Zivadinov

    Argitaratua 2010-01-01
    Testu osoa
    Artikulua
  14. 14
    Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination

    Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination nork Hiromitsu Asashima, Dongjoo Kim, Kaicheng Wang, Nikhil Lele, Nicholas C. Buitrago-Pocasangre, Rachel Lutz, Isabella Cruz, Khadir Raddassi, William E. Ruff, Michael K. Racke, JoDell E. Wilson, Tara S. Givens, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Steven H. Kleinstein, Ruth R. Montgomery, Albert C. Shaw, Fangyong Li, Rong Fan, David A. Hafler, Mary M. Tomayko, Erin E. Longbrake

    Argitaratua 2023-09-01
    Testu osoa
    Artikulua

Bilaketa egiteko lanabesak: